Načítá se...

S100A8 is a Novel Therapeutic Target for Anaplastic Thyroid Carcinoma

CONTEXT: Anaplastic thyroid carcinoma (ATC) is one of the most deadly human malignancies. It is 99% lethal, and patients have a median survival of only 6 months after diagnosis. Despite these grim statistics, the mechanism underlying the tumorigenic capability of ATC cells is unclear. OBJECTIVE: S10...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Endocrinol Metab
Hlavní autoři: Reeb, Ashley N., Li, Wen, Sewell, Will, Marlow, Laura A., Tun, Han W., Smallridge, Robert C., Copland, John A., Spradling, Kyle, Chernock, Rebecca, Lin, Reigh-Yi
Médium: Artigo
Jazyk:Inglês
Vydáno: Endocrine Society 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318889/
https://ncbi.nlm.nih.gov/pubmed/25423568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2988
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!